title: Belatacept (Nulojix) for prevention of renal transplant rejection.
mesh_terms: D000069594:Abatacept; D016207:Cytokines / Q000096:biosynthesis; D017277:Drug Approval; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016207:Cytokines; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept